Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2006-01-26
2008-10-07
Campell, Bruce (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S184100, C424S185100, C424S186100, C424S187100, C424S193100, C530S300000, C435S005000, C435S007200, C435S007210, C435S007240
Reexamination Certificate
active
07431928
ABSTRACT:
The invention relates to the identification and the selection of CTL epitopes able to induce a protection against an HIV infection. More particularly, the invention is concerned with peptides and nucleic acid sequence coding for these peptides derived from HIV-1 proteins such as GAG, POL, ENV, VIF, TAT, VPU, REV and their applications. Preferably the immunogenic peptides are selected from the group consisting of SEQ ID NOs:1 to 18 and functional derivatives thereof. The invention also relates to antibodies directed against said peptides.
REFERENCES:
patent: 5459060 (1995-10-01), Cotropia
patent: 6268484 (2001-07-01), Katinger et al.
patent: WO 9744667 (1997-11-01), None
patent: WO 99/45954 (1999-09-01), None
patent: WO 99/58658 (1999-11-01), None
patent: WO 01/24810 (2001-04-01), None
patent: WO 02/20035 (2002-03-01), None
Altman et al. HIV escape: there and back again. Nature Medicine Mar. 2004, vol. 10, No. 3, pp. 229-230.
Friedrich et al. Reversion of CTL escape—variant immunodeficiency viruses in vivo. Nature Medicine Mar. 2004, vol. 10, No. 3, pp. 275-281.
Leslie et al. HIV evolution: CTL escape mutation and reversion after transmission. Nature Medicine Mar. 2004, vol. 10, No. 3, pp. 282-289.
Desrosiers. Prospects for an AIDS vaccine. Nature Medicine Mar. 2004, vol. 10, No. 3, pp. 221-223.
Letvin. Progress toward an HIV vaccine, Annual Review of Medicine 2005, vol. 56, pp. 213-223.
Altfeld et al. Vpr Is Preferentially Targeted by CTL During HIV-1 Infection. The Journal of Immunology, Sep. 1, 2001, vol. 167, p. 2743-2752.
Altman et al. Phenotypic Analysis of Antigen-Specific T lymphocytes. Science Oct. 4, 1996, vol. 274, p. 94-96.
Altman et al. MHC Tetramer Analyses of CD8+ T Cell Responses to HIV and SIV. HIV Databases Review Artivle 1998 [online], Los Alamos National Laboratory, United States [retrieved on Jun. 26, 2007]. Retrieved from the Internet <URL: www.hiv.lanl.gov/content/hiv-dab/REVIEWS/articles/Safrit.html>.
Kusk et al. Mapping of a New Immunodominant Human Linear B-cell Epitope on the Vpu protein of the HIV-1 1993. Journal of Acquired Immune Deficiency Syndromes vol. 6. pp. 334-338.
Jin, X. et al., “Identification of Subdominant Cytotoxic T Lymphocyte Epitopes Encoded by Autologous HIV Type 1 Sequences, Using Dendritic Cell Stimulation and Computer-Driven Algorithm”, Aids Research and Human Retroviruses, vol. 16, pp. 67-76, (Nov. 1, 2000).
Los Alamos National Laboratory, HIV Database, Immunology Database, ′Online!—Dec. 2000, Retrieved from the Internet: url:http://hiv-web.lanl.gov/content/hiv-db/immunology/PDF/2000/2/alignments/p2p7p1p6.pdf, Retrieved on Jul. 14, 2003!
Aids Vaccine 2001, Posters Conference 2001, ′Online!—Sep. 8, 2001, XP-002247713, Retrieved from the Internet: URL:http://www.aidsvaccine2001.org/Posters/305.pdf, Retrieved on Jul. 15, 2003!
Kuroda et al., “Analysis of Gag-Specific Cytotoxic T Lymphocytes in Simian Immunodeficiency Virus-Infected Rhesus Monkeys by Cell Staining with a Tetrameric Major Histocompatibility Complex Class I-Peptide Complex,”J. Exp. Med., vol. 187, No. 9, May 4, 1998, p. 1373-1381.
Cardinaud Sylvain
Habel Andre
Langlade-Demoyen Pierre
Lemonnier François
Campell Bruce
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Humphrey Louise
Institut National de la Sante et de la Recherche
Institut Pasteur
LandOfFree
Identification of new CD8 epitopes from HIV-1 proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Identification of new CD8 epitopes from HIV-1 proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Identification of new CD8 epitopes from HIV-1 proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4002811